Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
The pivotal ConfIdeS study has finished enrollment and is now with the FDA. IdeS is imlifidase, with the brand name Idefirix. It has been conditionally approved by EMA and is on the market in Europe since 2020. Idefirix is a niche product, an orphan drug. It is a cysteine protease Continue reading Idefirix PDUFA Date and the IdeS of March
Hilarious: Chicks and Kids Antibiotic use in animals is defended as infection prophylaxis, but the honest reason why chickens are exposed for most days of their short life to antibiotics of various kinds is for growth promotion. Antibiotic use keeps those chicks healthy which in turn makes them eat more Continue reading Making The News: Something Hilarious, Something Ominous…